CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1-Reference-Cited by-同舟云学术

CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1

Published:2019-12-06 Issue:1 Volume:69 Page:103-114
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Erin Nuray^ORCID,Dilmaç Sayra,Curry Anna,Duymuş Özlem,Tanriover Gamze,Prodeus Aaron,Gariepy Jean,Gorczynski Reginald M.

Funder

Akdeniz Üniversitesi

Canadian Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-019-02444-3.pdf

Reference42 articles.

1. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M et al (2003) Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 171(6):3034–3046

2. Wright GJ, Puklavec MJ, Willis AC, Hoek RM, Sedgwick JD, Brown MH et al (2000) Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13(2):233–242

3. Erin N, Kale S, Tanriover G, Koksoy S, Duymus O, Korcum AF (2013) Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma. Breast Cancer Res Treat 139(3):677–689

4. Erin N, Podnos A, Tanriover G, Duymus O, Cote E, Khatri I et al (2015) Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response. Oncogene 34(29):3860–3870

5. Gorczynski RM, Chen Z, He W, Khatri I, Sun Y, Yu K et al (2009) Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts. J Immunol 183(3):1560–1568

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APTAMERS: NANOMATERIALS AS A POTENTIAL AGENT FOR ANTIVIRAL THERAPEUTIC DRUG DELIVERY DEVELOPMENT: A SYSTEMATIC LITERATURE REVIEW;International Journal of Applied Pharmaceutics;2024-01-07

2. ADAM10 and Neprilysin level decreases in immune cells of mice bearing metastatic breast carcinoma: Possible role in cancer inflammatory response;International Immunopharmacology;2024-01

3. Olvanil activates sensory nerve fibers, increases T cell response and decreases metastasis of breast carcinoma;Life Sciences;2022-02

4. Aptamer-mediated drug delivery system for cardiovascular diseases;Combination Drug Delivery Approach as an Effective Therapy for Various Diseases;2022

5. Effects of in-vitro modulation of TRPV1 activity on immune response of mice bearing metastatic breast carcinoma: Enhanced inflammatory response may hinder therapeutic potentials of TRPV1 agonists;Life Sciences;2021-12